TBLA vs. MRNA

Last updated Jun 3, 2026

TBLA (Taboola.com Ltd.) and MRNA (Moderna, Inc.) are both stocks. TBLA operates in Internet Content & Information (Communication Services), while MRNA operates in Biotechnology (Healthcare). Over the past 3 years, TBLA returned 18.11%/yr vs -29.55%/yr for MRNA. At a 0.24 correlation, their price movements are largely independent.

Performance

TBLA vs. MRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Taboola.com Ltd. (TBLA) and Moderna, Inc. (MRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TBLA achieves a 5.42% return, which is significantly lower than MRNA's 54.76% return.

TBLA

• 1D: -1.82%
• 1M: 28.23%
• YTD: 5.42%
• 6M: 19.70%
• 1Y: 33.52%
• 3Y*: 18.11%
• 5Y*: —
• 10Y*: —

MRNA

• 1D: -0.91%
• 1M: 0.60%
• YTD: 54.76%
• 6M: 89.69%
• 1Y: 68.72%
• 3Y*: -29.55%
• 5Y*: -25.22%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TBLA vs. MRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
TBLA Taboola.com Ltd.	5.42%	26.30%	-15.70%	40.58%	-60.41%	-24.83%
MRNA Moderna, Inc.	54.76%	-29.08%	-58.19%	-44.63%	-29.28%	8.09%

Correlation

The correlation between TBLA and MRNA is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (All Time) Calculated using the full available price history since Jul 1, 2021	0.24

Fundamentals

Market Cap TBLA : $1.40B MRNA : $18.03B
EPS TBLA : $0.36 MRNA : -$8.16
PS Ratio TBLA : 0.90 MRNA : 8.03
PB Ratio TBLA : 1.47 MRNA : 2.43
Total Revenue (TTM) TBLA : $1.65B MRNA : $2.23B
Gross Profit (TTM) TBLA : $579.78M MRNA : -$309.00M
EBITDA (TTM) TBLA : $210.19M MRNA : -$3.02B

Return for Risk

TBLA vs. MRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TBLA

TBLA Risk / Return Rank: 63
TBLA Sharpe Ratio Rank: 65
TBLA Sortino Ratio Rank: 68
TBLA Omega Ratio Rank: 63
TBLA Calmar Ratio Rank: 59
TBLA Martin Ratio Rank: 60

MRNA

MRNA Risk / Return Rank: 72
MRNA Sharpe Ratio Rank: 73
MRNA Sortino Ratio Rank: 73
MRNA Omega Ratio Rank: 68
MRNA Calmar Ratio Rank: 74
MRNA Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TBLA vs. MRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Taboola.com Ltd. (TBLA) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TBLA	MRNA	Difference
Sharpe ratio Return per unit of total volatility	0.76	1.09	-0.33
Sortino ratio Return per unit of downside risk	1.67	1.93	-0.26
Omega ratio Gain probability vs. loss probability	1.19	1.22	-0.03
Calmar ratio Return relative to maximum drawdown	0.87	2.02	-1.15
Martin ratio Return relative to average drawdown	2.01	4.02	-2.01
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TBLA vs. MRNA - Sharpe Ratio Comparison

The current TBLA Sharpe Ratio is 0.76, which is lower than the MRNA Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of TBLA and MRNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TBLA	MRNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.76	1.09	-0.33
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.38	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.24	0.18	-0.42

Drawdowns

TBLA vs. MRNA - Drawdown Comparison

The maximum TBLA drawdown since its inception was -84.76%, smaller than the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for TBLA and MRNA.

Drawdown Indicators

	TBLA	MRNA	Difference
Max Drawdown Largest peak-to-trough decline	-84.76%	-95.38%	+10.62%
Max Drawdown (1Y) Largest decline over 1 year	-36.01%	-35.51%	-0.50%
Max Drawdown (3Y) Largest decline over 3 years	-47.84%	-86.58%	+38.74%
Max Drawdown (5Y) Largest decline over 5 years	—	-95.38%	—
Current Drawdown Current decline from peak	-53.71%	-90.58%	+36.87%
Average Drawdown Average peak-to-trough decline	-60.57%	-56.62%	-3.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.58%	17.87%	-2.29%

Volatility

TBLA vs. MRNA - Volatility Comparison

Taboola.com Ltd. (TBLA) has a higher volatility of 24.99% compared to Moderna, Inc. (MRNA) at 17.07%. This indicates that TBLA's price experiences larger fluctuations and is considered to be riskier than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TBLA	MRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.99%	17.07%	+7.92%
Volatility (6M) Calculated over the trailing 6-month period	34.86%	48.11%	-13.25%
Volatility (1Y) Calculated over the trailing 1-year period	44.42%	63.55%	-19.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.25%	66.32%	-7.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.25%	71.89%	-12.64%

Dividends

TBLA vs. MRNA - Dividend Comparison

Neither TBLA nor MRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both TBLA and MRNA in my portfolio?

TBLA and MRNA have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TBLA or MRNA?

TBLA has higher volatility (24.99%) compared to MRNA (17.07%). In terms of maximum drawdown, TBLA dropped -84.76% vs MRNA's -95.38%.

Which has better risk-adjusted returns?

MRNA currently has the higher Sharpe Ratio (1.09 vs 0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.